Average Co-Inventor Count = 4.02
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (19 from 3,681 patents)
2. E. R. Squibb Sons, Inc. (6 from 1,624 patents)
3. Other (3 from 832,680 patents)
4. Astrazeneca Ab (1,500 patents)
28 patents:
1. RE44186 - Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
2. 8278462 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
3. 7705033 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
4. 7420079 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
5. 6995183 - Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
6. 6995180 - Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods
7. 6984645 - Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
8. 6927227 - Heterocyclic containing biphenyl aP2 inhibitors and method
9. 6548529 - Heterocyclic containing biphenyl aP2 inhibitors and method
10. 6472414 - Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
11. 6395767 - Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
12. 6087349 - Method for blocking neoplastic transformation of cells induced by ras
13. 6066650 - Inhibitors of microsomal triglyceride transfer protein and method
14. 6034098 - Inhibitors of microsomal triglyceride transfer protein and method
15. 5883099 - Inhibitors of microsomal triglyceride transfer protein and method